Abstract:OBJECT Craniopharyngiomas (CPs) are rare epithelial tumors that are often associated with an enigmatic and unpredictable growth pattern. Understanding the growth patterns of these tumors has a direct impact on surgical planning and may enhance the safety of radical tumor removal. The aim of this study was to analyze the growth patterns and surgical treatment of CPs with a focus on the involvement of the hypothalamopituitary axis and the relationship of the tumor to the arachnoid membrane and surrounding structures. METHODS Clinical data from 226 consecutive patients with primary CP were retrospectively reviewed. Tumor location and the relationship of the tumor to the third ventricle floor and the pituitary stalk were evaluated using preoperative MRI and intraoperative findings. A topographic classification scheme was proposed based on the site of tumor origin and tumor development. The clinical relevance of this classification on patient presentation and outcomes was also analyzed. RESULTS The growth of CPs can be broadly divided into 3 groups based on the site of tumor origin and on tumor-meningeal relationships: Group I, infrasellar/infradiaphragmatic CPs (Id-CPs), which mainly occurred in children; Group II, suprasellar subarachnoid extraventricular CPs (Sa-CPs), which were mainly observed in adults and rarely occurred in children; and Group III, suprasellar subpial ventricular CPs (Sp-CPs), which commonly occurred in both adults and children. Tumors in each group may develop complex growth patterns during vertical expansion along the pituitary stalk. Tumor growth patterns were closely related to both clinical presentation and outcomes. Patients with Sp-CPs had more prevalent weight gain than patients with Id-CPs or Sa-CPs; the rates of significant weight gain were 41.7% for children and 16.7% for adults with Sp-CPs, 2.2% and 7.1% for those with Id-CPs, and 12.5% and 2.6% for those with Sa-CPs (p < 0.001). Moreover, patients with Sp-CPs had increased hypothalamic dysfunction after radical removal; 39% of patients with Sp-CPs, 14.5% with Id-CPs, and 17.4% with Sa-CPs had high-grade hypothalamic dysfunction in the first 2 postoperative years (p < 0.001). CONCLUSIONS The classification of CPs based on growth pattern may elucidate the best course of treatment for this formidable tumor. More tailored, individualized surgical strategies based on tumor growth patterns are mandatory to provide long-term tumor control and to minimize damage to hypothalamic structures. Differences in the distribution of growth patterns between children and adults imply that hierarchical comparison is necessary when investigating outcomes and survival across treatment paradigms in patients with CP.

Growth of Craniopharyngioma Involving the Third Ventricular Floor in Relation to the Hypothalamus

Inflammation and cellular proliferation in different types of craniopharyngioma

Inflammatory Response in Craniopharyngiomas and Its Clinical Significance

Reinvestigating Tumor–Ventricle Relationship of Craniopharyngiomas with Predominantly Ventricular Involvement: an Endoscopic Endonasal Series Based on Histopathological Assessment

Impact of Third Ventricle Invasion Pattern by Large Craniopharyngiomas on the Outcome of Surgical Tumor Resection

Relationship Between Inflammation of Craniopharyngioma and Postoperative Diabetes Insipidus

Membrane Structures Between Craniopharyngioma And The Third Ventricle Floor Based On The Qst Classification And Its Significance: A Pathological Study

Relationship Between Craniopharyngioma and the Third Ventricle Floor Meninges Based on QST Classification

Intraventricular Craniopharyngioma: Morphological Analysis and Outcome Evaluation of 17 Cases

The Study on the Expression of IFn-α and TGF-β1 in Different Types of Craniopharyngiomas

Relationship Between Inflammation and Clinicopathological Indicators and Clinical Outcomes in Craniopharyngioma

Expression of Interferon-Α Receptor and Proliferating Cell Nuclear Antigen in Craniopharyngioma

Detection of ICAM-1mRNA expression in two types of craniopharyngioma using SYBR real-time PCR

Expression of Periostin in Craniopharyngioma Involving Third Ventricular Floor and its Relationship to Hypothalamus Functions

Expression and clinical significance of growth hormone receptor in craniopharyngioma

Expression of Integrin Αvβ3 in Craniopharyngioma and Its Correlation with Prognosis

Microsurgical Resection of Craniopharyngioma of the Third Ventricle Via an Improved Transventricular Approach

18F-Choline PET Detected the Third Ventricle Craniopharyngioma

Growth Patterns of Craniopharyngiomas: Clinical Analysis of 226 Patients.

Research on the correlativity of expressions of CXCL12 and CXCR4 with the invasiveness and recurrence of adamantimous craniopharyngiomas

Expression of Insulin-Like Growth Factor Type 1 Receptor is Linked to Inflammation in Adamantinomatous Craniopharyngioma.